Intestinal epithelial cells and mucosal surface (IEC)

The intestinal epithelial cells and mucosal surface constitute a complex biological barrier that lines the gastrointestinal tract, serving as the primary site for nutrient absorption and immune surveillance (Source: StatPearls, NBK541032). This system consists of a specialized layer of epithelial cells—including enterocytes, goblet cells, and Paneth cells—covered by a protective mucus layer that sequesters commensal bacteria and neutralizes pathogens (Source: Nature Reviews Immunology, doi:10.1038/nri.2017.106). In diseases such as Crohn's disease and ulcerative colitis, the integrity of this mucosal barrier is compromised, leading to increased permeability and chronic inflammation (Source: Frontiers in Immunology, doi:10.3389/fimmu.2023.1151693). Therapeutic strategies often focus on protecting this surface or delivering drugs locally to minimize systemic side effects, as seen with 5-aminosalicylates or enteric-coated steroids (Source: Mayo Clinic). However, because this term describes a multi-cellular tissue and anatomical region rather than a specific protein or receptor, it is classified as a physiological site rather than a discrete molecular target (Source: PubChem).

Other names

Intestinal barrierGut epitheliumIntestinal mucosaEnteric epitheliumGastrointestinal mucosal barrier

Drugs interacting with this site typically function by providing local anti-inflammatory effects, activating epithelial ion channels (e.g., ClC-2 or GC-C) to promote fluid secretion, or enhancing mucosal repair and barrier integrity.